KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Change in Account Payables: 2009-2024

Historic Change in Account Payables for Rigel Pharmaceuticals (RIGL) over the last 16 years, with Dec 2024 value amounting to -$3.8 million.

  • Rigel Pharmaceuticals' Change in Account Payables fell 48.77% to -$3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31,000, marking a year-over-year increase of 100.74%. This contributed to the annual value of -$3.8 million for FY2024, which is 939.07% down from last year.
  • As of FY2024, Rigel Pharmaceuticals' Change in Account Payables stood at -$3.8 million, which was down 939.07% from -$366,000 recorded in FY2023.
  • In the past 5 years, Rigel Pharmaceuticals' Change in Account Payables registered a high of $3.8 million during FY2022, and its lowest value of -$3.8 million during FY2024.
  • For the 3-year period, Rigel Pharmaceuticals' Change in Account Payables averaged around -$127,000, with its median value being -$366,000 (2023).
  • Per our database at Business Quant, Rigel Pharmaceuticals' Change in Account Payables soared by 9,139.02% in 2022 and then plummeted by 939.07% in 2024.
  • Over the past 5 years, Rigel Pharmaceuticals' Change in Account Payables (Yearly) stood at -$331,000 in 2020, then skyrocketed by 112.39% to $41,000 in 2021, then surged by 9,139.02% to $3.8 million in 2022, then plummeted by 109.66% to -$366,000 in 2023, then slumped by 939.07% to -$3.8 million in 2024.